Management of Midostaurin-CYP3A4 Drug-Drug Interactions in Patients With Acute Myeloid Leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology (Williston Park, N.Y.) N.Y.), 2019-07, Vol.33 (7), p.274
1. Verfasser:	Schlafer, Danielle
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute leukemia Acute myelocytic leukemia Cancer research Chemotherapy Cytochrome P-450 Cytochrome P-450 CYP3A - metabolism Cytochrome P-450 CYP3A Inhibitors - metabolism Cytochrome P-450 CYP3A Inhibitors - therapeutic use Dosage and administration Drug Interactions Drug therapy fms-Like Tyrosine Kinase 3 - antagonists & inhibitors Genes Health aspects Humans Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - metabolism Leukemia, Myeloid, Acute - pathology Micafungin Midostaurin Myeloid leukemia Operating systems (Software) Phenols (Class of compounds) Physiological aspects Posaconazole Protein Kinase Inhibitors - therapeutic use Randomized Controlled Trials as Topic Resveratrol Staurosporine - analogs & derivatives Staurosporine - metabolism Staurosporine - therapeutic use Tyrosine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0890-9091